Search Results - "Picard, O"

Early drug and anti‐infliximab antibody levels for prediction of primary nonresponse to infliximab therapy by Bar‐Yoseph, H., Levhar, N., Selinger, L., Manor, U., Yavzori, M., Picard, O., Fudim, E., Kopylov, U., Eliakim, R., Ben‐Horin, S., Chowers, Y., Ungar, B.

“…Summary Background Primary nonresponse, defined as lack of clinical benefit during the induction phase, occurs in up to 30% of IBD patients treated with…”
Get full text

Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab by Ungar, B., Kopylov, U., Engel, T., Yavzori, M., Fudim, E., Picard, O., Lang, A., Williet, N., Paul, S., Chowers, Y., Bar‐Gil Shitrit, A., Eliakim, R., Ben‐Horin, S., Roblin, X.

“…Summary Background Anti‐adalimumab antibodies (AAA) are associated with loss of clinical response (LOR). Addition of an immunomodulator has been shown to…”
Get full text

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis by Ungar, B., Mazor, Y., Weisshof, R., Yanai, H., Ron, Y., Goren, I., Waizbard, A., Yavzori, M., Fudim, E., Picard, O., Loebstein, R., Kopylov, U., Dotan, I., Chowers, Y., Eliakim, R., Ben‐Horin, S.

“…Summary Background Infliximab is effective as salvage therapy for patients with steroid refractory acute severe ulcerative colitis (UC). Although current data…”
Get full text

The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful by Ben-Horin, Shomron, Yavzori, Miri, Katz, Lior, Kopylov, Uri, Picard, Orit, Fudim, Ella, Coscas, Daniel, Bar-Meir, Simon, Goldstein, Itamar, Chowers, Yehuda

“…To localise the immunogenic part of infliximab and evaluate the clinical usefulness of measuring antibodies against infliximab fragments. Observational study…”
Get more information

Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti‐tumour necrosis factor by Ben‐Horin, S., Ungar, B., Kopylov, U., Lahat, A., Yavzori, M., Fudim, E., Picard, O., Peled, Y., Eliakim, R., Del Tedesco, E., Paul, S., Roblin, X.

“…Summary Background Data on combination‐biologic treatment in (IBD) are still scant. Aim To explore outcomes of patients co‐exposed to anti‐TNF and vedolizumab…”
Get full text

The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD by Ben-Horin, S., Mazor, Y., Yanai, H., Ron, Y., Kopylov, U., Yavzori, M., Picard, O., Fudim, E., Maor, Y., Lahat, A., Coscas, D., Eliakim, R., Dotan, I., Chowers, Y.

“…Summary Background Anti‐drug antibodies can be elicited by infliximab and adalimumab, but the rate of their decay after therapy is stopped is unknown. Aim To…”
Get full text

Characterization of hepatitis delta infection in Israel: prevalence and genotypes by Shirazi, R, Ram, D, Rakovsky, A, Gozlan, Y, Bucris, E, Shaked-Mishan, P, Picard, O, Shemer-Avni, Y, Ben-Zvi, H, Halutz, O, Mor, O, Lurie, Y, Safadi, R, Ben-Ari, Z

Get full text

Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines by Ben-Horin, S, Goldstein, I, Fudim, E, Picard, O, Yerushalmi, Z, Barshack, I, Bank, I, Goldschmid, Y, Meir, S Bar, Mayer, L, Chowers, Y

“…The onset of the effect of thiopurines is delayed for several months. The aim of this study was to investigate immune mechanisms for this delay. The effects of…”
Get more information

Berberine Alone and in Conjunction With Immunomodulators Down-regulates Pro-inflammatory CD4+ T-Cells: Implications for a Combined Treatment of Inflammatory Bowel Diseases by Salomon, N, Fudim, E, Picard, O, Yavzori, M, Gamus, D, Elyakim, R, Ben-Horin, S

Get full text

Lidocaine down‐regulates nuclear factor‐κB signalling and inhibits cytokine production and T cell proliferation by Lahat, A., Horin, S. B., Lang, A., Fudim, E., Picard, O., Chowers, Y.

“…Summary Lidocaine is a commonly used local anaesthetic agent which has also been found to possess anti‐inflammatory activity in several disorders. However, the…”
Get full text

Defining and investigating occupational asthma: a consensus approach by Francis, H C, Prys-Picard, C O, Fishwick, D, Stenton, C, Burge, P S, Bradshaw, L M, Ayres, J G, Campbell, S M, Niven, R McL

“…Background: At present there is no internationally agreed definition of occupational asthma and there is a lack of guidance regarding the resources that should…”
Get full text

47 TESTING FOR HEPATITIS B VIRUS (HBV) ALONE DOES NOT INCREASE VACCINE COVERAGE IN NON-IMMUNIZED PERSONS by Bottero, J, Boyd, A, Gozlan, J, Lemoine, M, Collignon, A, Boo, N, Dhotte, P, Varsat, B, Charlois, C, Cha, O, Picard, O, Pauti, M.-D, Campa, P, Silbermann, B, Bary, M, Rougier, H, Girard, P.-M, Lacombe, K

Get full text

Disproportionate breathlessness associated with deep sighing breathing in a patient presenting with difficult-to-treat asthma by Prys-Picard, Curig O, Kellett, Fiona, Niven, Robert M

“…Disproportionate breathlessness is a term that is used synonymously with dysfunctional breathing and idiopathic hyperventilation in the absence of chest…”
Get more information

982 PERFORMANCE OF RAPID TESTS FOR DETECTION OF HEPATITIS B SURFACE ANTIGEN (HBSAG) AND ANTI HEPATITIS B SURFACE ANTIBODY (ANTI-HBSAB) IN A LARGE COHORT, FRANCE by Bottero, J, Gozlan, J, Boyd, A, Lemoine, M, Collignon, A, Boo, N, Dhotte, P, Varsat, B, Muller, G, Cha, O, Picard, O, Nau, J, Campa, P, Silbermann, B, Bary, M, Girard, P.-M, Lacombe, K

Get full text

24 MISSED OPPORTUNITIES FOR HBV SCREENING: RESULTS OF A LARGE SCREENING CAMPAIGN IN THE COMMUNITY, FRANCE 2011 by Bottero, J, Boyd, A, Lemoine, M, Gozlan, J, Collignon, A, Boo, N, Dhotte, P, Varsat, B, Muller, G, Cha, O, Nau, J, Campa, P, Picard, O, Silbermann, B, Bary, M, Girard, P.-M, Lacombe, K

Get full text

Urinary incontinence in patients with bronchiectasis by Prys-Picard, C O, Niven, R

Get full text

Hepatotoxicity associated with ritonavir by Picard, O, Rosmorduc, O, Cabane, J

Get full text

Defining and investigating difficult asthma: Developing quality indicators by Prys-Picard, C.O., Campbell, S.M., Ayres, J.G., Miles, J.F., Niven, R.M.

“…There is no agreed definition of ‘difficult asthma’ or what investigations should be available to investigate these patients. Patients with difficult asthma…”
Get full text

Outcomes of Patients on Multiple Vasoactive Drugs for Shock by Prys-Picard, Curig O., Shah, Shiwan K., Williams, Brandie D., Cardenas, Victor, Sharma, Gulshan

“…Introduction:Vasoactive drugs are routinely used in critically ill patients with shock to optimize the hemodynamic state while evaluating and treating…”
Get full text

Health related quality of life and lipodystrophy syndrome among HIV-infected patients by Préau, M, Bouhnik, A-D, Spire, B, Leport, C, Saves, M, Picard, O, Reynes, J, Salmon, D, Dellamonica, P, Raffi, F, Morin, M, Aproco-Copilote, Etlegrouped'étude

“…The aim of this work is to show to what extent a psychosocial evaluation can lead bring to comprehension of the subjectivity of Quality of Life (QoL) among…”
Get more information